(Q49697799)

English

The frequency and management of asparaginase‐related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute consortium protocols

scientific article published on January 7, 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols (English)

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

The frequency and management of asparaginase‐related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute consortium protocols (English)

1 reference

10.1111/J.1365-2141.2010.08524.X

https://api.crossref.org/works/10.1111/J.1365-2141.2010.08524.X

21 November 2024

0 references

0 references

1 reference

based on heuristic

inferred from title

Ellis J Neufeld

6

object named as

Ellis J Neufeld

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

3

object named as

Donna Neuberg

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

Rachael F Grace

1

object named as

Rachael F. Grace

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

Suzanne E Dahlberg

2

object named as

Suzanne E. Dahlberg

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

author name string

Stephen E. Sallan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

Jean M. Connors

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

Daniel J. Deangelo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

Lewis B. Silverman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

language of work or name

0 references

publication date

7 January 2011

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2010.08524.x

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

https://europepmc.org/articles/PMC5763913

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

https://europepmc.org/articles/PMC5763913?pdf=render

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

https://doi.org/10.1111/j.1365-2141.2010.08524.x

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21210774

21 November 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.2010.08524.x

1 reference

10.1111/J.1365-2141.2010.08524.X

https://api.crossref.org/works/10.1111/J.1365-2141.2010.08524.X

21 November 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2141.2010.08524.x

1 reference

10.1111/J.1365-2141.2010.08524.X

https://api.crossref.org/works/10.1111/J.1365-2141.2010.08524.X

21 November 2024

British Journal of Haematology

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

152

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

4

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

452-459

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Thrombosis and acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Increased risk of venous thromboembolism in patients with acute leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Effects of Erwinia-asparaginase on the coagulation system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL stu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

2 November 2018

Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08524.X

21 January 2018

Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developmental haemostasis. Impact for clinical haemostasis laboratories

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in coagulation and fibrinolysis in childhood ALL: a two-step dose reduction of one E. coli asparaginase preparation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2010.08524.X

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49697799&oldid=2277927109"